Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Emery

Showing results (231-240 of 517) with videos related to

Pageof 52
Sort By:
Human Vaccines|March 15, 2008
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapyS Emery, A D Kelleher, C Workman, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
AIDS (London, England)|January 11, 2000
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in ThailandK Ruxrungtham, S Suwanagool, J A Tavel, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2017
On the synthesis of quinone-based BODIPY hybrids: New insights on antitumor activity and mechanism of action in cancer cellsTalita B Gontijo, Rossimiriam P de Freitas, Flavio S Emery, et al.
International Immunopharmacology|January 22, 2013
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophilsMicássio F Andrade, Luciana M Kabeya, Ana Elisa C S Azzolini, et al.
NAM Journal|June 29, 2026
New approach methodologies for evaluating developmental and reproductive toxicity potential: Review on state of the art, applicability for cosmetic related ingredients and coverage of developmental stagesM Burbank, N J Hewitt, F Gautier, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase ActivationTemitayo O Alegbejo Price, Daniel G Silva, Miguel M Vaidergorn, et al.
European Journal of Medicinal Chemistry|August 21, 2018
β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove bindersMiguel M Vaidergorn, Zumira A Carneiro, Carla D Lopes, et al.
Lancet (London, England)|June 18, 2013
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study, M A Boyd, N Kumarasamy, et al.
Obesity (Silver Spring, Md.)|September 25, 2016
Genetic variation near IRS1 is associated with adiposity and a favorable metabolic profile in U.S. Hispanics/LatinosQibin Qi, Stephanie M Gogarten, Leslie S Emery, et al.
Pageof 52

Showing results (231-240 of 517) with videos related to

Sort By:
Pageof 52
Human Vaccines|March 15, 2008
Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapyS Emery, A D Kelleher, C Workman, et al.
Clinical Pharmacology and Therapeutics|June 6, 2015
Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 StudyL Dickinson, J Amin, L Else, et al.
AIDS (London, England)|January 11, 2000
A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in ThailandK Ruxrungtham, S Suwanagool, J A Tavel, et al.
Bioorganic & Medicinal Chemistry Letters|August 19, 2017
On the synthesis of quinone-based BODIPY hybrids: New insights on antitumor activity and mechanism of action in cancer cellsTalita B Gontijo, Rossimiriam P de Freitas, Flavio S Emery, et al.
International Immunopharmacology|January 22, 2013
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophilsMicássio F Andrade, Luciana M Kabeya, Ana Elisa C S Azzolini, et al.
NAM Journal|June 29, 2026
New approach methodologies for evaluating developmental and reproductive toxicity potential: Review on state of the art, applicability for cosmetic related ingredients and coverage of developmental stagesM Burbank, N J Hewitt, F Gautier, et al.
ACS Medicinal Chemistry Letters|June 17, 2026
5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase ActivationTemitayo O Alegbejo Price, Daniel G Silva, Miguel M Vaidergorn, et al.
European Journal of Medicinal Chemistry|August 21, 2018
β-amino alcohols and their respective 2-phenyl-N-alkyl aziridines as potential DNA minor groove bindersMiguel M Vaidergorn, Zumira A Carneiro, Carla D Lopes, et al.
Lancet (London, England)|June 18, 2013
Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study, M A Boyd, N Kumarasamy, et al.
Obesity (Silver Spring, Md.)|September 25, 2016
Genetic variation near IRS1 is associated with adiposity and a favorable metabolic profile in U.S. Hispanics/LatinosQibin Qi, Stephanie M Gogarten, Leslie S Emery, et al.
Pageof 52